openPR Logo
Press release

Demand for the Molecular Diagnostics Reagent Market is projected to reach a value of US$ 20,009 million by 2034

02-19-2024 03:45 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Fact.MR

Demand for the Molecular Diagnostics Reagent Market

The global molecular diagnostics reagent market (分子診断試薬市場) is projected to grow at a CAGR of 6.6% from 2024 to 2034. By 2034, the market is expected to reach a demand of US$ 20,009.6 million, up from an estimated market size of US$ 10,584.3 million in 2024.

Market Dynamics:

Molecular diagnostics has emerged as a powerful tool in the field of medicine, enabling the detection and monitoring of diseases at the molecular level. The market for molecular diagnostics reagents is driven by several factors, including the increasing prevalence of infectious diseases and cancer, growing demand for personalized medicine, and advancements in technology.

For More Insights into the Market, Request a Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=9576

Another major driver is the rising demand for personalized medicine, which requires precise and targeted diagnostic tests. Molecular diagnostics reagents enable healthcare providers to tailor treatment plans according to the patient's genetic makeup, leading to more effective outcomes.

Technological advancements have also contributed to the growth of the market, with the development of more sensitive and specific reagents that offer faster and more accurate results. This has led to the adoption of molecular diagnostics in a wide range of applications, including oncology, infectious diseases, and genetic testing.

List of Key Companies Profiled in The Report

Becton, Dickinson and Company
Bio-Rad Laboratories Inc
Thermo Fisher Scientific Inc.
Merck KGaA
Agilent Technologies, Inc.
Qiagen N.V.
Illumina, Inc.
DiaSorin S.p.A
Hologic Inc.

Market Future Outlook:

The molecular diagnostics reagent market is expected to continue its growth trajectory in the coming years, driven by factors such as the increasing adoption of molecular diagnostics in clinical practice, the growing focus on precision medicine, and the rising demand for point-of-care testing.

The market is also likely to benefit from the ongoing research and development activities in the field of molecular diagnostics, which are aimed at developing new reagents and technologies that offer better performance and greater efficiency.

Market Insights:

The global molecular diagnostics reagent market is segmented based on product type, application, end-user, and region. By product type, the market is divided into PCR reagents, DNA sequencing reagents, microarray reagents, and others.

Want Full Report? Enquire Here- https://www.factmr.com/report/molecular-diagnostics-reagent-market

By application, the market is categorized into infectious diseases, oncology, genetic testing, and others. The infectious diseases segment is expected to dominate the market, owing to the increasing prevalence of these diseases and the high demand for rapid diagnostic tests.

Recent Developments:

In September 2021, F. Hoffmann-La Roche Ltd. announced the acquisition of TIB Molbiol (Germany) to enhance its portfolio of PCR tests with a wide range of assays for infectious diseases.

Bio-Rad Laboratories, Inc. launched the Reliance SARS-CoV-2/FluA/FluB RT-PCR Kit in July 2021, designed for in-vitro diagnosis. The kit includes assay reagents, standard, and negative molecular controls.

In March 2021, Roche announced its merger with GenMark Diagnostics, aiming to access advanced molecular diagnostics technology. This collaboration enables the screening of various infections using a single patient sample, expanding Roche's geographic reach and accelerating business growth.

Hologic, Inc. acquired Biotheranostics Inc. (United States) in January 2021 to broaden its molecular diagnostics offerings.

In December 2020, GeneIQ in Dallas shifted its focus to address the COVID-19 pandemic, leading to significant company expansion.

Abbott introduced a molecular point-of-care test in March 2020, capable of diagnosing COVID-19 in five minutes. This test, the company's second for COVID-19, received FDA emergency use authorization.

Explore More Related Studies Published by Fact.MR Research:

PCR Reagents Market (PCR試薬市場): https://www.factmr.com/report/pcr-reagents-market

In Vitro Diagnostic (IVD) Reagent Market (体外診断(IVD)試薬市場): https://www.factmr.com/report/5058/in-vitro-diagnostic-ivd-reagent-market

Cationic Reagent Market (カチオン試薬市場): https://www.factmr.com/report/cationic-reagent-market

Contact:

US Sales Office

11140 Rockville Pike

Suite 400 Rockville, MD 20852

United States Tel: +1 (628) 251-1583, +353-1-4434-232 (D)

Sales Team: sales@factmr.com

About Fact.MR :

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Demand for the Molecular Diagnostics Reagent Market is projected to reach a value of US$ 20,009 million by 2034 here

News-ID: 3389948 • Views:

More Releases from Fact.MR

Bioinformatics Market is Growing at a CAGR of 13.4% by 2034 | Fact.MR Report
Bioinformatics Market is Growing at a CAGR of 13.4% by 2034 | Fact.MR Report
The latest report on the Bioinformatics Market, projecting robust growth driven by the increasing demand for genomic research, advancements in artificial intelligence (AI), and the rising adoption of precision medicine. Valued at USD 14.29 billion in 2024, the global market is forecast to expand at a compound annual growth rate (CAGR) of 13.4%, reaching USD 50.25 billion by 2034. This significant growth underscores the critical role of bioinformatics in decoding
Residential Robotic Vacuum Cleaner Market to Reach USD 11.6 Billion by 2033 | Key Players: iRobot Corporation, Neato Robotics, Inc., Yujin Robot, Co., Ltd., and Dyson Inc
Residential Robotic Vacuum Cleaner Market to Reach USD 11.6 Billion by 2033 | Ke …
Fact.MR today released its latest report on the Residential Robotic Vacuum Cleaner Market, projecting robust growth driven by increasing demand for automation, busy lifestyles, and advancements in smart home technologies. Valued at USD 3.0 billion in 2023, the global market is forecast to expand at a compound annual growth rate (CAGR) of 14.4%, reaching USD 11.6 billion by 2033. This significant growth highlights the rising adoption of robotic vacuum cleaners
Brain-Computer Interface Market is Estimated to Reach USD 6.5 Billion by 2033
08-29-2025 | Health & Medicine
Fact.MR
Brain-Computer Interface Market is Estimated to Reach USD 6.5 Billion by 2033
The global brain-computer interface (BCI) market was valued at USD 1.6 billion in 2022 and is projected to reach USD 6.5 billion by 2033, growing at a compound annual growth rate (CAGR) of 13.6% from 2023 to 2033. This expansion reflects the increasing adoption of BCI technologies in medical applications, driven by advancements in neuroscience, AI, and sensor technologies. BCIs enable direct communication between the brain and external devices, offering
Orally Disintegrating Tablet Market is Projected to Reach USD 72.68 Billion by 2034 | Key Players: Johnson & Johnson Services Inc; Teva Pharmaceutical Industries Ltd.; Sun Pharmaceutical Industries Ltd.; Takeda Pharmaceutical Company Limited
08-29-2025 | Health & Medicine
Fact.MR
Orally Disintegrating Tablet Market is Projected to Reach USD 72.68 Billion by 2 …
The global orally disintegrating tablet (ODT) market is valued at USD 24.45 billion in 2024 and is forecasted to expand at a compound annual growth rate (CAGR) of 11.5%, reaching USD 72.68 billion by 2034. This robust growth is driven by the increasing demand for patient-friendly dosage forms, particularly among the elderly, pediatric, and dysphagic populations, who benefit from ODTs' ease of administration without water and rapid dissolution. ODTs enhance

All 5 Releases


More Releases for Reagent

Chromatography And Spectroscopy Reagent Market Size Analysis by Application, Typ …
According to Market Research Intellect, the global Chromatography And Spectroscopy Reagent market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period. The growing need for sophisticated analytical methods in biotechnology, pharmaceuticals, environmental testing, and food safety is
Global Biotechnology Reagent Market Size by Application, Type, and Geography: Fo …
USA, New Jersey- According to Market Research Intellect, the global Biotechnology Reagent market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period. The Biotechnology Reagent market is experiencing steady growth as advancements in research and development, coupled with an increased demand for diagnostic tools, drive the need
Global Trifolirhizin Reagent Market Analysis by 2020-2025
Scope of the Report: The global Trifolirhizin Reagent market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. Market segmentation Trifolirhizin Reagent market is split by Type and by Application. For the period 2015-2025, the growth among segments
Haptoglobin Reagent Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Haptoglobin Reagent Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Haptoglobin Reagent players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Haptoglobin Reagent with respect to individual growth
Immunodiagnostic Reagent Market Size, Share, Development by 2024
LP INFORMATION offers a latest published report on Immunodiagnostic Reagent Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. According to this study, over the next five years the Immunodiagnostic Reagent market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular,
Global Reagent Market Research Report
This report studies the global Reagent market status and forecast, categorizes the global Reagent market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Roche Siemens Abbott Beckman BD Johnson & Johnson BioMerieux Bio-Rad Sysmex Randox Grifols KHB BioSino Leadman Fosun Pharma BSBE